CLINICAL CHARACTERISTICS OF BREAST CANCER WITH STEROID RECEPTORS EXPRESSION AND HER2 AMPLIFICATION
Since the middle of the previous century the heterogeneity of breast cancer became absolutely evident. This assumption was historically based on differences in clinical behavior and sensitivity to therapy. Treatment approach nowadays is based primarily on clinical and morphological prognostic...
Main Authors: | F. V. Moiseenko, V. F. Semiglazov, T. Yu. Semiglazova, A. A. Bogdanov, I. E. Eliseev, A. O. Ivantsov, N. А. Knyasev, I. N. Terterov, А. A. Kornev, M. V. Dubina |
---|---|
Format: | Article |
Language: | English |
Published: |
Bashkir State Medical University
2017-02-01
|
Series: | Креативная хирургия и онкология |
Subjects: | |
Online Access: | https://www.surgonco.ru/jour/article/view/178 |
Similar Items
-
Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01) -
Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer
by: Iveta Kolarova, et al.
Published: (2019-12-01) -
Status of estrogene, progesterone receptors and HER-2/neu expression in invasive breast cancer
by: Naghshvar F, et al.
Published: (2007-01-01) -
STUDY OF THE EFFECT OF LOMUSTIN ON HER2-POSITIVE BREAST CANCER IN FVB/N HER-2 TRANSGENIC MICE
by: A. N. Stukov, et al.
Published: (2019-11-01) -
Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series
by: Rusz O, et al.
Published: (2018-09-01)